Sweden's Medicover Q2 revenue rises on Polish sports/wellness growth

Medicover AB

22/07/2026 06:55

    

    Overview
  
Sweden healthcare and diagnostics firm's Q2 revenue rose 7% year-over-year
Basic EPS for Q2 increased 27% year-over-year
Q2 operating profit rose 23% with margin improving to 8.0%

    

    Outlook
  
Medicover says it enters the second half of the yr with confidence and improving margins
Company expects continued organic growth and opportunities in Poland, Romania, Germany and India
Company says margin improvement and organic growth remain priorities for the rest of the yr

    

    Result Drivers
  
ORGANIC GROWTH - Double-digit organic revenue growth of 11.8% drove results, with price increases contributing about 5.2 percentage points
POLISH SPORTS/WELLNESS AND INDIA - Strong development in the Polish sports/wellness business and double-digit growth in India were key drivers for Healthcare Services
DIAGNOSTIC SERVICES MARGIN IMPROVEMENT - Margin improvement in Diagnostic Services reflected operational efficiencies, a favorable revenue mix, and faster growth in advanced test volumes

    
Company press release: ID:nMFN6yTlm6

    

    Key Details
  

            Metric
          

            Beat/Miss
          

            Actual
          

            Consensus Estimate
          
Q2 Revenue
 
EUR 640.40 mln
 
Q2 Basic EPS
 
EUR 0.16
 
Q2 EBIT
 
EUR 51.20 mln
 
Q2 EBIT Margin
 
8.00%
 

    

    Analyst Coverage
  
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Medicover AB is SEK277.50, about 26.1% above its July 21 closing price of SEK220.00
The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 24 three months ago

    

    Reuters Recommended Reads
  
July 21 - Sweden's Asker Healthcare Q2 profit jumps on increased scale
July 21 - Sweden's MedCap Q2 net sales rise 16% on organic growth and acquisitions
July 20 - Sweden's Devyser Diagnostics Q2 sales fall on distributor inventory adjustment

    
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)